Veeva partners with Amgen to speed up clinical trials

* Veeva Systems (NYSE:VEEV [https://seekingalpha.com/symbol/VEEV]) said on Thursday it is partnering with Amgen to enhance end-to-end clinical trial operations using the Veeva Clinical Platform, aiming to speed up drug development.
* "In collaboration with Veeva, we're leveraging advanced technology to unlock new capabilities for our end-to-end trial operations which are expected to further strengthen our ability to bring innovative treatments to patients with speed and scale" Amgen CEO, Skellenger said in a statement.
* VEEV -4.63% premarket to $280.0
* Source: Press Release [https://seekingalpha.com/pr/20214344-veeva-announces-collaboration-with-global-biotech-to-further-accelerate-clinical-trial]

MORE ON VEEVA SYSTEMS

* Veeva Systems Inc. (VEEV) Q2 2026 Earnings Call Transcript [https://seekingalpha.com/article/4817353-veeva-systems-inc-veev-q2-2026-earnings-call-transcript]
* Veeva Systems Inc. 2026 Q2 - Results - Earnings Call Presentation [https://seekingalpha.com/article/4817307-veeva-systems-inc-2026-q2-results-earnings-call-presentation]
* Veeva Systems: Growth Momentum Remains Strong [https://seekingalpha.com/article/4799916-veeva-systems-growth-momentum-remains-strong]
* Veeva signals expanded opportunity in commercial cloud and AI following IQVIA resolution [https://seekingalpha.com/news/4489832-veeva-signals-expanded-opportunity-in-commercial-cloud-and-ai-following-iqvia-resolution]
* Veeva Systems Non-GAAP EPS of $1.99 beats by $0.09, revenue of $789.1M beats by $20.37M [https://seekingalpha.com/news/4489741-veeva-systems-non-gaap-eps-of-1_99-beats-by-0_09-revenue-of-789_1m-beats-by-20_37m]